These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22421586)

  • 1. Restless legs syndrome responsive to rasagiline treatment: a case report.
    Babacan-Yildiz G; Gursoy E; Kolukisa M; Celebi A
    Clin Neuropharmacol; 2012; 35(2):88-9. PubMed ID: 22421586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics of Restless legs syndrome in patients with Parkinson's disease.
    Nomura T; Inoue Y; Nakashima K
    J Neurol Sci; 2006 Dec; 250(1-2):39-44. PubMed ID: 16899256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH; Klasser M; Reichmann H
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of ropinirole in patients with restless legs syndrome and a baseline IRLS total score > or = 24 points--data from the ropinirole clinical trial programme.
    Giorgi L; Ritchie SY; Kirsch JM
    Curr Med Res Opin; 2006 Oct; 22(10):1867-77. PubMed ID: 17022844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The reliability, validity and responsiveness of the International Restless Legs Syndrome Study Group rating scale and subscales in a clinical-trial setting.
    Abetz L; Arbuckle R; Allen RP; Garcia-Borreguero D; Hening W; Walters AS; Mavraki E; Kirsch JM
    Sleep Med; 2006 Jun; 7(4):340-9. PubMed ID: 16713344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restless legs syndrome in Parkinson's disease.
    Gómez-Esteban JC; Zarranz JJ; Tijero B; Velasco F; Barcena J; Rouco I; Lezcano E; Lachen MC; Jauregui A; Ugarte A
    Mov Disord; 2007 Oct; 22(13):1912-6. PubMed ID: 17579369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease.
    Chen JJ; Swope DM; Dashtipour K
    Clin Ther; 2007 Sep; 29(9):1825-49. PubMed ID: 18035186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term open-label study of pramipexole in patients with primary restless legs syndrome.
    Inoue Y; Kuroda K; Hirata K; Uchimura N; Kagimura T; Shimizu T
    J Neurol Sci; 2010 Jul; 294(1-2):62-6. PubMed ID: 20451927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients.
    Stern MB; Marek KL; Friedman J; Hauser RA; LeWitt PA; Tarsy D; Olanow CW
    Mov Disord; 2004 Aug; 19(8):916-23. PubMed ID: 15300656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rasagiline treatment effects on parkinsonian tremor.
    Lew MF
    Int J Neurosci; 2013 Dec; 123(12):859-65. PubMed ID: 23767986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study.
    Parkinson Study Group
    Arch Neurol; 2005 Feb; 62(2):241-8. PubMed ID: 15710852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics of leg restlessness in Parkinson's disease compared with idiopathic Restless Legs Syndrome.
    Zhu XY; Liu Y; Zhang XJ; Yang WH; Feng Y; Ondo WG; Tan EK; Wu YC
    J Neurol Sci; 2015 Oct; 357(1-2):109-14. PubMed ID: 26189051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute.
    García-Borreguero D; Allen RP; Kohnen R; Högl B; Trenkwalder C; Oertel W; Hening WA; Paulus W; Rye D; Walters A; Winkelmann J; Earley CJ;
    Sleep Med; 2007 Aug; 8(5):520-30. PubMed ID: 17544323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient- and physician-rated measures demonstrate the effectiveness of ropinirole in the treatment of restless legs syndrome.
    Kushida CA; Geyer J; Tolson JM; Asgharian A
    Clin Neuropharmacol; 2008; 31(5):281-6. PubMed ID: 18836346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of high dose pergolide mesilate on restless legs syndrome associated with Parkinson disease].
    Imamura A; Tsuboi Y; Tanaka M; Obata T; Yamada T
    Rinsho Shinkeigaku; 2007 Apr; 47(4):156-9. PubMed ID: 17511286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rasagiline-associated motor improvement in PD occurs without worsening of cognitive and behavioral symptoms.
    Elmer L; Schwid S; Eberly S; Goetz C; Fahn S; Kieburtz K; Oakes D; Blindauer K; Salzman P; Oren S; Prisco UL; Stern M; Shoulson I; ;
    J Neurol Sci; 2006 Oct; 248(1-2):78-83. PubMed ID: 16828804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rasagiline improves quality of life in patients with early Parkinson's disease.
    Biglan KM; Schwid S; Eberly S; Blindauer K; Fahn S; Goren T; Kieburtz K; Oakes D; Plumb S; Siderowf A; Stern M; Shoulson I;
    Mov Disord; 2006 May; 21(5):616-23. PubMed ID: 16450340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of vitamins C, E, and their combination for treatment of restless legs syndrome in hemodialysis patients: a randomized, double-blind, placebo-controlled trial.
    Sagheb MM; Dormanesh B; Fallahzadeh MK; Akbari H; Sohrabi Nazari S; Heydari ST; Behzadi S
    Sleep Med; 2012 May; 13(5):542-5. PubMed ID: 22317944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of restless legs syndrome in end-stage renal failure and idiopathic RLS patients.
    Enomoto M; Inoue Y; Namba K; Munezawa T; Matsuura M
    Mov Disord; 2008 Apr; 23(6):811-6; quiz 926. PubMed ID: 18074382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rasagiline: defining the role of a novel therapy in the treatment of Parkinson's disease.
    Stocchi F
    Int J Clin Pract; 2006 Feb; 60(2):215-21. PubMed ID: 16451296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.